Dr. David Dong Qi Zhang, MD

Dr. Zhang practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Zhang's NPI, 1679242903, was assigned on September 9, 2021. Dr. Zhang graduated from McGill University Faculty of Medicine in 2014. Dr. Zhang holds Florida license 34155.

Dr. Zhang's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Zhang's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Zhang is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 2 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Zhang is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Zhang is licensed in Florida.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Zhang treats.

CMS data shows 151 Medicare services from Dr. Zhang across 6 procedure codes in 2024, for 111 Medicare patients. Medicare paid $11,356 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 66, with 44% women.

In 2024, Dr. Zhang wrote 141 Medicare Part D claims for 86 patients. 87% of them were for generic drugs. CMS names the drug for 75 of them, across 3 drugs with 11 or more claims each, at $720 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Zhang for performance year 2024, reported as part of a group. Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhang as offering telehealth. CMS counts 33 procedures of colonoscopy by Dr. Zhang, more than 55% of the clinicians it reports for that procedure.

CMS Open Payments shows 38 general payments to Dr. Zhang from 4 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 45% of the total. Intuitive Surgical, Inc. paid the most, $8,099.

Dr. Zhang graduated from McGill University Faculty of Medicine in 2014.

Dr. Zhang is in network with 9 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.